Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2000
11/30/2000WO2000043037A3 Hiv-encoded chemoattractant
11/30/2000WO2000043028A3 Method of treating chronic cardiac disease
11/30/2000WO2000042188A3 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000041546A3 Novel exendin agonist formulations and methods of administration thereof
11/30/2000WO2000041509A3 Polypeptides having acid phosphatase activity and nucleic acids encoding same
11/30/2000WO2000040700A3 Oocyte activation by sperm components
11/30/2000WO2000040695A3 Sequence-determined dna fragments and corresponding polypeptides encoded thereby
11/30/2000WO2000040694A3 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants
11/30/2000WO2000040606A3 Modulation of hiv replication using sam68
11/30/2000WO2000034481A3 DRUG TARGETS IN $i(CANDIDA ALBICANS)
11/30/2000WO2000032777A3 Scorpion toxins
11/30/2000WO2000032772A9 Erythropoietic compounds
11/30/2000WO2000031254A3 Apoptosis-inducing factor
11/30/2000WO2000029846A3 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-α MEDIATED PATHWAY
11/30/2000WO2000028027A3 Corticosteroid synthesis-associated genes
11/30/2000WO2000027871A3 New family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs
11/30/2000WO2000026380A9 Rotavirus subunit vaccine
11/30/2000WO2000025725A3 Functional antagonists of hedgehog activity
11/30/2000WO2000024895A3 Method and model for hair pigmentation
11/30/2000WO2000022136A3 Recombinant e1a deleted adenoviral vectors
11/30/2000WO2000018918A3 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/30/2000WO2000012704A3 Enhanced functional expression of g protein-coupled receptors
11/30/2000WO2000009658A8 Gene regulating circadian clock function and photoperiodism
11/30/2000EP1144624A3 Human and mouse trek-1 potassium channel protein and their use
11/30/2000DE19924199A1 Tumorassoziiertes Antigen Tumor-associated antigen
11/30/2000DE19922942A1 Apparatus for the photolithographic illumination of biological substances, useful in the manufacture of DNA chips, includes a micromirror array controlled to produce any given illumination pattern
11/30/2000CA2838395A1 Combination neisserial compositions
11/30/2000CA2382774A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000CA2375032A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics
11/30/2000CA2374918A1 Identification of novel mechanisms of drug resistance
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374550A1 Antigenic neisserial peptides
11/30/2000CA2374520A1 Secreted alpha-helical protein - 32
11/30/2000CA2374517A1 Inducible packaging cell lines for lentivirus vectors
11/30/2000CA2374507A1 Assay for the detection of paclitaxel resistant cells in human tumors
11/30/2000CA2374497A1 Method for generating split, non-transferable genes that are able to express an active protein product
11/30/2000CA2374432A1 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000CA2374379A1 Novel gene controlling ethylene synthesis
11/30/2000CA2374375A1 Promoter having specific activity to pistil tissue and use of the same
11/30/2000CA2374364A1 Polypeptides and polynucleotides from moraxella catarrhalis
11/30/2000CA2374354A1 Immunogenic peptides derived from mage and the use thereof
11/30/2000CA2374341A1 Novel polypeptide
11/30/2000CA2374273A1 Liver function controlling agents
11/30/2000CA2374070A1 Tagged epitope protein transposable element
11/30/2000CA2374050A1 Vascular endothelial growth factor dimers
11/30/2000CA2374021A1 Methods for regulating protein conformation using molecular chaperones
11/30/2000CA2374019A1 Models of prion disease
11/30/2000CA2373822A1 Vascular endothelial growth factor variants
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373588A1 Gene therapy of pulmonary disease
11/30/2000CA2373285A1 Diagnosis and treatment of atherosclerosis and coronary heart disease
11/30/2000CA2373262A1 Therapeutic uses of bpi protein products in humans with otitis media with effusion
11/30/2000CA2373236A1 Combination neisserial compositions
11/30/2000CA2371828A1 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000CA2371500A1 Expression products of genes involved in diseases related to cholesterol metabolism
11/30/2000CA2370332A1 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants
11/29/2000EP1055729A1 Transgenic plants exhibiting an altered flowering time
11/29/2000EP1055685A1 Non-antigenic branched polymer conjugates
11/29/2000EP1055684A1 Tumor antigen peptide derivatives
11/29/2000EP1055429A1 Novel preventives/remedies for immunopathy
11/29/2000EP1055366A1 Use of transgenic mice lacking jun-b expression in the myeloid lineage
11/29/2000EP1055126A1 Methods and compositions for diagnosis of hepatoma
11/29/2000EP1055125A2 Interaction between cyclin d1 and steroid receptor co-activators
11/29/2000EP1054995A1 GABAB-R2a, A 7TM RECEPTOR
11/29/2000EP1054991A1 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
11/29/2000EP1054990A2 Expression vector for the production of dead proteins
11/29/2000EP1054988A1 Anti-viral vectors
11/29/2000EP1054987A1 Insecticidal peptides
11/29/2000EP1054985A2 Hybrid seed production
11/29/2000EP1054984A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
11/29/2000EP1054983A1 Antagonists of g-protein-coupled receptor
11/29/2000EP1054973A1 Antigen library immunization
11/29/2000EP1054972A2 Insecticidal toxins from photorhabdus
11/29/2000EP1054971A2 Group b streptococcus antigens
11/29/2000EP1054970A1 Pollen specific promoter
11/29/2000EP1054969A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
11/29/2000EP1054968A1 Apoptosis inducing molecule ii and methods of use
11/29/2000EP1054967A1 Connective tissue growth factor homologs
11/29/2000EP1054966A1 Ammaid, a g protein coupled receptor
11/29/2000EP1054965A2 Members of the d52 gene family
11/29/2000EP1054964A1 Members of the d52 gene family
11/29/2000EP1054963A1 Sequences of an ih ionic channel and the use thereof
11/29/2000EP1054962A2 Caf1-related protein
11/29/2000EP1054961A2 Human short-chain tnf-receptor family protein
11/29/2000EP1054959A1 High efficiency methods and compositions for integrating exogenous dna into genomic dna of sperm
11/29/2000EP1054958A1 Human serine protease and serpin polypeptides
11/29/2000EP1054950A2 Hiv chemokines
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054903A1 Fishboy, a g-protein coupled receptor
11/29/2000EP1054902A1 Agents for the prevention of damages caused by stress conditions
11/29/2000EP1054901A2 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
11/29/2000EP1054900A1 Therapeutic uses of keratinocyte growth factor-2
11/29/2000EP1054899A2 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON $g(b)-CATENIN, AND THE PRODUCTION AND USE THEREOF
11/29/2000EP1054898A1 Neuroprotective peptides and uses thereof
11/29/2000EP1054897A1 METHOD FOR PURIFYING PrPres FROM A BIOLOGICAL SAMPLE AND APPLICATIONS
11/29/2000EP1054896A1 ANALGESIC PEPTIDES FROM VENOM OF $i(GRAMMOSTOLA SPATULATA) AND USE THEREOF
11/29/2000EP1054895A1 Novel peptide diagnostic reagent and kit for detection of rickettsiosis
11/29/2000EP1054894A1 Breast cancer resistance protein (bcrp) and the dna which encodes it
11/29/2000EP1054893A1 Synthetic polymers and methods, kits or compositions for modulating the solubility of same